Iceland vs South-Eastern Asia: Proportion of the target population who received the final dose of
Iceland
89.0%
in 2024
South-Eastern Asia
51.0%
in 2024
Iceland rank
11th
South-Eastern Asia rank
13th
Proportion of the target population who received the final dose of over time
- Iceland
- South-Eastern Asia
How they compare
Iceland currently reports 89.0% against 51.0% in South-Eastern Asia, a difference of 38.0%.
That makes Iceland's figure about 1.7 times South-Eastern Asia's.
Across all 13 years both countries report, Iceland has been ahead every year.
Iceland ranks 11th and South-Eastern Asia ranks 13th of 107 countries.
Iceland has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Iceland | South-Eastern Asia | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 89.0% | 6.9% | 82.1% | Iceland |
| 2020s | 87.6% | 19.2% | 68.4% | Iceland |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher proportion of the target population who received the final dose of, Iceland or South-Eastern Asia?
- Iceland, at 89.0% against 51.0% in South-Eastern Asia as of 2024.
- What is the difference in proportion of the target population who received the final dose of between Iceland and South-Eastern Asia?
- 38.0%, with Iceland ahead.
- How many years of comparable data are there for Iceland and South-Eastern Asia?
- 13 years are reported by both, from 2012 to 2024.
- How do Iceland and South-Eastern Asia rank globally for proportion of the target population who received the final dose of?
- Iceland ranks 11th and South-Eastern Asia ranks 13th of 107 countries.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Proportion of the target population who received the final dose of human papillomavirus (HPV) vaccine (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.